Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hemoperfusion in Combination With Hemodialysis for Improvement of Self-reported Sleep Disturbance and Overall Survival Rate in Maintenance Hemodialysis Patients

NCT03487146 is registered in ClinicalTrials.gov with Shanghai Pudong Hospital as lead sponsor.

NCT NCT03487146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03487146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hemoperfusion in Combination With Hemodialysis for Improvement of Self-reported Sleep Disturbance and Overall Survival Rate in Maintenance Hemodialysis Patients
Lead sponsor
Shanghai Pudong Hospital
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2015
Completion date
December 1, 2017
Enrollment
156 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hemoperfusion